Jean Mulinde from CDER’s Office of Scientific Investigations describes the casic characteristics of clinical trials of quality. She discusses the roles that quality management systems, quality by design principles, and risk-based monitoring play in ensuring data reliability and trial participant protection in the clinical development of new medicinal products.
For more data integrity case studies, visit [ Ссылка ]
_______________________________
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.
Upcoming training and free continuing education credits: [ Ссылка ]
CDER SBIA 2018 Playlist: [ Ссылка ]
LinkedIn: [ Ссылка ]
Training resources: [ Ссылка ]
Twitter: [ Ссылка ]
CDER small business e-mail update subscription: [ Ссылка ]
Email: CDERSBIA@fda.hhs.gov
Phone: (301) 796-6707 I (866) 405-5367
